BW-50218
/ Argo Biopharma
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
September 04, 2026
Study of BW-50218 in Healthy Participants
(clinicaltrials.gov)
- P1 | N=60 | Active, not recruiting | Sponsor: Shanghai Argo Biopharmaceutical Co., Ltd. | Recruiting ➔ Active, not recruiting
Enrollment closed
June 25, 2026
A Phase 1 Study of Single-Dose BW-50218 in Healthy Chinese Participants
(clinicaltrials.gov)
- P1 | N=24 | Active, not recruiting | Sponsor: Shanghai Argo Biopharmaceutical Co., Ltd. | Recruiting ➔ Active, not recruiting
Enrollment closed
June 05, 2026
A Phase 1 Study of Single-Dose BW-50218 in Healthy Chinese Participants
(clinicaltrials.gov)
- P1 | N=24 | Recruiting | Sponsor: Shanghai Argo Biopharmaceutical Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open
May 12, 2026
A Phase 1 Study of Single-Dose BW-50218 in Healthy Chinese Participants
(clinicaltrials.gov)
- P1 | N=24 | Not yet recruiting | Sponsor: Shanghai Argo Biopharmaceutical Co., Ltd.
New P1 trial
1 to 4
Of
4
Go to page
1